» Articles » PMID: 34386323

Targeted Inhibition of GRK2 Kinase Domain by CP-25 to Reverse Fibroblast-like Synoviocytes Dysfunction and Improve Collagen-induced Arthritis in Rats

Overview
Publisher Elsevier
Specialty Pharmacology
Date 2021 Aug 13
PMID 34386323
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Rheumatoid arthritis (RA) is an autoimmune disease and is mainly characterized by abnormal proliferation of fibroblast-like synoviocytes (FLS). The up-regulated cellular membrane expression of G protein coupled receptor kinase 2 (GRK2) of FLS plays a critical role in RA progression, the increase of GRK2 translocation activity promotes dysfunctional prostaglandin E4 receptor (EP4) signaling and FLS abnormal proliferation. Recently, although our group found that paeoniflorin-6'--benzene sulfonate (CP-25), a novel compound, could reverse FLS dysfunction GRK2, little is known as to how GRK2 translocation activity is suppressed. Our findings revealed that GRK2 expression up-regulated and EP4 expression down-regulated in synovial tissues of RA patients and collagen-induced arthritis (CIA) rats, and prostaglandin E2 (PGE2) level increased in arthritis. CP-25 could down-regulate GRK2 expression, up-regulate EP4 expression, and improve synovitis of CIA rats. CP-25 and GRK2 inhibitors (paroxetine or GSK180736A) inhibited the abnormal proliferation of FLS in RA patients and CIA rats by down-regulating GRK2 translocation to EP4 receptor. The results of microscale thermophoresis (MST), cellular thermal shift assay, and inhibition of kinase activity assay indicated that CP-25 could directly target GRK2, increase the protein stability of GRK2 in cells, and inhibit GRK2 kinase activity. The docking of CP-25 and GRK2 suggested that the kinase domain of GRK2 might be an important active pocket for CP-25. G201, K220, K230, A321, and D335 in kinase domain of GRK2 might form hydrogen bonds with CP-25. Site-directed mutagenesis and co-immunoprecipitation assay further revealed that CP-25 down-regulated the interaction of GRK2 and EP4 controlling the key amino acid residue of Ala321 of GRK2. Our data demonstrate that FLS proliferation is regulated by GRK2 translocation to EP4. Targeted inhibition of GRK2 kinase domain by CP-25 improves FLS function and represents an innovative drug for the treatment of RA by targeting GRK2.

Citing Articles

Inhibition of GRK2-PDE4D Axis Suppresses Fibroblast-Like Synoviocytes Hyperplasia and Alleviates Experimental Arthritis.

Han D, Sun H, Zhang R, Ge H, Guo P, Chu R Int J Biol Sci. 2025; 21(4):1513-1529.

PMID: 39990667 PMC: 11844291. DOI: 10.7150/ijbs.100176.


High-fat diet stimulated butyric acid metabolism dysbiosis, altered microbiota, and aggravated inflammatory response in collagen-induced arthritis rats.

Liu Y, Zhang Y, Zhang J, Ren S, Cao Q, Kong H Nutr Metab (Lond). 2024; 21(1):95.

PMID: 39563394 PMC: 11577678. DOI: 10.1186/s12986-024-00869-x.


GRK2 mediates cisplatin-induced acute liver injury via the modulation of NOX4.

Wang Q, Li M, Duan F, Xiao K, Sun Q, Cheng J Cell Biol Toxicol. 2024; 40(1):98.

PMID: 39546067 PMC: 11567994. DOI: 10.1007/s10565-024-09940-y.


G protein-coupled receptor kinase 2 as a novel therapeutic target for gland fibrosis of Sjögren's syndrome.

Fang R, Zhou Z, Chu R, Guan Q, He F, Ge M Acta Pharmacol Sin. 2024; 45(12):2611-2624.

PMID: 39054339 PMC: 11579508. DOI: 10.1038/s41401-024-01350-4.


Macrophage-derived mir-100-5p orchestrates synovial proliferation and inflammation in rheumatoid arthritis through mTOR signaling.

Liu H, Chen Y, Huang Y, Wei L, Ran J, Li Q J Nanobiotechnology. 2024; 22(1):197.

PMID: 38644475 PMC: 11034106. DOI: 10.1186/s12951-024-02444-1.


References
1.
Kojima F, Naraba H, Sasaki Y, Beppu M, Aoki H, Kawai S . Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts. Arthritis Rheum. 2003; 48(10):2819-28. DOI: 10.1002/art.11261. View

2.
Davies R, Southwood T, Kearsley-Fleet L, Lunt M, Hyrich K . Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Arthritis Rheumatol. 2015; 67(9):2487-94. PMC: 5049649. DOI: 10.1002/art.39197. View

3.
Yang X, Zhao Y, Jia X, Wang C, Wu Y, Zhang L . CP-25 combined with MTX/ LEF ameliorates the progression of adjuvant-induced arthritis by the inhibition on GRK2 translocation. Biomed Pharmacother. 2018; 110:834-843. DOI: 10.1016/j.biopha.2018.12.040. View

4.
Chang Y, Wu Y, Wang D, Wei W, Qin Q, Xie G . Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responses. Rheumatology (Oxford). 2010; 50(5):862-70. DOI: 10.1093/rheumatology/keq404. View

5.
Aragay A, Mellado M, Frade J, Martin A, Martinez-A C, Mayor Jr F . Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2. Proc Natl Acad Sci U S A. 1998; 95(6):2985-90. PMC: 19681. DOI: 10.1073/pnas.95.6.2985. View